Form 6-K GLAXOSMITHKLINE PLC For: Oct 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
GlaxoSmithKline plc (GSK) Reports Q3 EPS of GBP0.08
October 22, 2014 7:04 AM EDTGlaxoSmithKline plc (NYSE: GSK) reported Q3 EPS of GBP0.08, versus GBP0.20 reported last year. Revenue for the quarter came in at GBP5.65 million, versus GBP6.51 million reported last year.
For earnings history and earnings-related data on GlaxoSmithKline plc (GSK) click here.
... More


